206 related articles for article (PubMed ID: 30252131)
1. Sialylation of vasorin by ST3Gal1 facilitates TGF-β1-mediated tumor angiogenesis and progression.
Yeo HL; Fan TC; Lin RJ; Yu JC; Liao GS; Chen ES; Ho MY; Lin WD; Chen K; Chen CH; Hung JT; Wu JC; Chang NC; Chang MD; Yu J; Yu AL
Int J Cancer; 2019 Apr; 144(8):1996-2007. PubMed ID: 30252131
[TBL] [Abstract][Full Text] [Related]
2. Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer.
Wu X; Zhao J; Ruan Y; Sun L; Xu C; Jiang H
Cell Death Dis; 2018 Oct; 9(11):1102. PubMed ID: 30375371
[TBL] [Abstract][Full Text] [Related]
3. Sialylation of CD55 by ST3GAL1 Facilitates Immune Evasion in Cancer.
Lin WD; Fan TC; Hung JT; Yeo HL; Wang SH; Kuo CW; Khoo KH; Pai LM; Yu J; Yu AL
Cancer Immunol Res; 2021 Jan; 9(1):113-122. PubMed ID: 33177111
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal feedback regulation of ST3GAL1 and GFRA1 signaling in breast cancer cells.
Fan TC; Yeo HL; Hsu HM; Yu JC; Ho MY; Lin WD; Chang NC; Yu J; Yu AL
Cancer Lett; 2018 Oct; 434():184-195. PubMed ID: 30040982
[TBL] [Abstract][Full Text] [Related]
5. ST3GAL1-Associated Transcriptomic Program in Glioblastoma Tumor Growth, Invasion, and Prognosis.
Chong YK; Sandanaraj E; Koh LW; Thangaveloo M; Tan MS; Koh GR; Toh TB; Lim GG; Holbrook JD; Kon OL; Nadarajah M; Ng I; Ng WH; Tan NS; Lim KL; Tang C; Ang BT
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26547933
[TBL] [Abstract][Full Text] [Related]
6. Vasorin stimulates malignant progression and angiogenesis in glioma.
Liang W; Guo B; Ye J; Liu H; Deng W; Lin C; Zhong X; Wang L
Cancer Sci; 2019 Aug; 110(8):2558-2572. PubMed ID: 31215106
[TBL] [Abstract][Full Text] [Related]
7. Human B Cell Differentiation Is Characterized by Progressive Remodeling of O-Linked Glycans.
Giovannone N; Antonopoulos A; Liang J; Geddes Sweeney J; Kudelka MR; King SL; Lee GS; Cummings RD; Dell A; Barthel SR; Widlund HR; Haslam SM; Dimitroff CJ
Front Immunol; 2018; 9():2857. PubMed ID: 30619255
[TBL] [Abstract][Full Text] [Related]
8. Increased α2-6 sialylation of endometrial cells contributes to the development of endometriosis.
Choi HJ; Chung TW; Choi HJ; Han JH; Choi JH; Kim CH; Ha KT
Exp Mol Med; 2018 Dec; 50(12):1-12. PubMed ID: 30542051
[TBL] [Abstract][Full Text] [Related]
9. Overlapping and unique substrate specificities of ST3GAL1 and 2 during hematopoietic and megakaryocytic differentiation.
Zhang N; Lin S; Cui W; Newman PJ
Blood Adv; 2022 Jul; 6(13):3945-3955. PubMed ID: 35507766
[TBL] [Abstract][Full Text] [Related]
10. Analyses of chicken sialyltransferases related to O-glycosylation.
Kidani S; Kaneoka H; Okuzaki Y; Asai S; Kojima Y; Nishijima K; Iijima S
J Biosci Bioeng; 2016 Oct; 122(4):379-84. PubMed ID: 27150510
[TBL] [Abstract][Full Text] [Related]
11. Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis.
Chiodelli P; Rezzola S; Urbinati C; Federici Signori F; Monti E; Ronca R; Presta M; Rusnati M
Oncogene; 2017 Nov; 36(47):6531-6541. PubMed ID: 28783175
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the specificity of sialyltransferases toward mucin core 2, globo, and related structures. identification of the sialylation sequence and the effects of sulfate, fucose, methyl, and fluoro substituents of the carbohydrate chain in the biosynthesis of selectin and siglec ligands, and novel sialylation by cloned alpha2,3(O)sialyltransferase.
Chandrasekaran EV; Xue J; Xia J; Chawda R; Piskorz C; Locke RD; Neelamegham S; Matta KL
Biochemistry; 2005 Nov; 44(47):15619-35. PubMed ID: 16300412
[TBL] [Abstract][Full Text] [Related]
13. Modification of α2,6-sialylation mediates the invasiveness and tumorigenicity of non-small cell lung cancer cells in vitro and in vivo via Notch1/Hes1/MMPs pathway.
Yuan Q; Chen X; Han Y; Lei T; Wu Q; Yu X; Wang L; Fan Z; Wang S
Int J Cancer; 2018 Nov; 143(9):2319-2330. PubMed ID: 29981167
[TBL] [Abstract][Full Text] [Related]
14. A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-glycans.
Whitehouse C; Burchell J; Gschmeissner S; Brockhausen I; Lloyd KO; Taylor-Papadimitriou J
J Cell Biol; 1997 Jun; 137(6):1229-41. PubMed ID: 9182658
[TBL] [Abstract][Full Text] [Related]
15. Coactosin-like protein CLP/Cotl1 suppresses breast cancer growth through activation of IL-24/PERP and inhibition of non-canonical TGFβ signaling.
Xia L; Xiao X; Liu WL; Song Y; Liu TJJ; Li YJ; Zacksenhaus E; Hao XJ; Ben-David Y
Oncogene; 2018 Jan; 37(3):323-331. PubMed ID: 28925397
[TBL] [Abstract][Full Text] [Related]
16. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
17. alpha 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo.
Hedlund M; Ng E; Varki A; Varki NM
Cancer Res; 2008 Jan; 68(2):388-94. PubMed ID: 18199532
[TBL] [Abstract][Full Text] [Related]
18. Enzymatic basis for N-glycan sialylation: structure of rat α2,6-sialyltransferase (ST6GAL1) reveals conserved and unique features for glycan sialylation.
Meng L; Forouhar F; Thieker D; Gao Z; Ramiah A; Moniz H; Xiang Y; Seetharaman J; Milaninia S; Su M; Bridger R; Veillon L; Azadi P; Kornhaber G; Wells L; Montelione GT; Woods RJ; Tong L; Moremen KW
J Biol Chem; 2013 Nov; 288(48):34680-98. PubMed ID: 24155237
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of cancerous progression by LISCH7 via direct stimulation of TGFB1 transcription in triple-negative breast cancer.
Tang X; Zhou Y; Liu Y; Zhang W; Liu C; Yan C
J Cell Biochem; 2020 Nov; 121(11):4642-4653. PubMed ID: 32048750
[TBL] [Abstract][Full Text] [Related]
20. Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells.
Park JJ; Yi JY; Jin YB; Lee YJ; Lee JS; Lee YS; Ko YG; Lee M
Biochem Pharmacol; 2012 Apr; 83(7):849-57. PubMed ID: 22266356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
